3 ‘undesirable’ trends in GI endoscopy

Some improvement has occurred in gastrointestinal endoscopy quality measures in the last year but there has been deterioration in three clinical indicators, a new report shows. Released by the Australian Council on Healthcare Standards, the latest clinical indicator report shows...

Some improvement has occurred in gastrointestinal endoscopy quality measures in the last year but there has been deterioration in three...

IBD

Blood test pattern can avoid diagnostic delay in IBD

Changes in standard blood tests up to one year before a diagnosis of IBD might be key to identifying the disease earlier. According to a Queensland study of 838 patients diagnosed with IBD from 1996 to 2014, a laboratory pattern...

Changes in standard blood tests up to one year before a diagnosis of IBD might be key to identifying the...

Cancer

QIMR: Prospect of biomarkers for oesophageal cancer

A panel of serum glycoprotein biomarkers can discriminate between patients with Barrett's oesophagus who do not require further intervention and those who have progressed to oesophageal adenocarcinoma. The research, led by a team at QIMR Berghofer Medical Research Institute, holds...

A panel of serum glycoprotein biomarkers can discriminate between patients with Barrett's oesophagus who do not require further intervention and...

Hepatology

NASH grows as indication for liver transplant

While hepatitis C (HCV) currently remains the leading indication for liver transplant in Australia and New Zealand, non-alcoholic steatohepatitis (NASH) is expected to eventually take over given the drivers of overweight, obesity and diabetes. NASH currently sits third behind both HCV...

While hepatitis C (HCV) currently remains the leading indication for liver transplant in Australia and New Zealand, non-alcoholic steatohepatitis (NASH)...